Molecular Response to Treatment of Chronic Myeloid Leukemia at University Teaching Hospital of Kigali, Rwanda: One-Arm Open Label Prospective Observational Study
{{output}}
Background: Chronic myeloid leukemia (CML) is among most common chronic hematological neoplasms marked by proliferation of granulocytes. Since 2001, the introduction of tyrosine kinase inhibitors (TKI), especially imatinib, the o... ...
